COVID-19, severe asthma, and biologics

MeSH terms

• Acetates / therapeutic use
• Adrenergic beta-2 Receptor Antagonists / therapeutic use*
• Amoxicillin-Potassium Clavulanate Combination / therapeutic use
• Anti-Asthmatic Agents / therapeutic use*
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Asthma / complications
• Asthma / drug therapy*
• Asthma / immunology
• Asthma / virology
• Azithromycin / therapeutic use
• Betacoronavirus / immunology
• Betacoronavirus / pathogenicity*
• Budesonide / therapeutic use
• COVID-19
• Convalescence
• Coronavirus Infections / complications
• Coronavirus Infections / drug therapy*
• Coronavirus Infections / immunology
• Coronavirus Infections / virology
• Cyclopropanes
• Eosinophils / drug effects
• Eosinophils / immunology
• Eosinophils / virology
• Female
• Humans
• Hydroxychloroquine / therapeutic use
• Ipratropium / therapeutic use
• Male
• Middle Aged
• Pandemics
• Pneumonia, Viral / complications
• Pneumonia, Viral / drug therapy*
• Pneumonia, Viral / immunology
• Pneumonia, Viral / virology
• Quinolines / therapeutic use
• SARS-CoV-2
• Sulfides
• Treatment Outcome